 PRINCETON, N.J., Oct. 08, 2021 GLOBE NEWSWIRE -- Agile Therapeutics, Inc. Nasdaq: AGRX, a womens healthcare company, today announced the pricing of its underwritten public offering of 26,666,648 shares of its common stock and warrants to purchase 13,333,324 shares of its common stock at a combined offering price to the public of 0.85 per one share of common stock and one-half of a warrant to purchase one share of common stock. The warrants have an exercise price of 0.85 per share of common stock, are exercisable immediately, and will expire five years from the date of issuance. The gross proceeds from the offering, before deducting underwriting discounts and commissions and estimated offering expenses payable by Agile Therapeutics, are expected to be approximately 22,666,650. All securities in the offering will be sold by Agile Therapeutics. 